Credit Suisse’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $8 | Sell |
|
|||||
|
2022
Q3 | $2K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $302K | Buy |
|
|||||
|
2021
Q4 | $316K | Buy |
|
|||||
|
2021
Q3 | $396K | Buy |
|
|||||
|
2021
Q2 | $529K | Sell |
|
|||||
|
2021
Q1 | $701K | Sell |
|
|||||
|
2020
Q4 | $1.34M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $57K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $226K | Sell |
|
|||||
|
2018
Q1 | $230K | Sell |
|
|||||
|
2017
Q4 | $161K | Sell |
|
|||||
|
2017
Q3 | $1.51M | Buy |
|
|||||
|
2017
Q2 | $146K | Buy |
|
|||||
|
2017
Q1 | $123K | Sell |
|
|||||
|
2016
Q4 | $446K | Buy |
|
|||||
|
2016
Q3 | $189K | Buy |
|
|||||
|
2016
Q2 | $86K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $667K | Buy |
|